“Osteoprotegerin, C- Reactive Protein and Fibroblast Growth Factor-23 in Stage (II-IV) CKD Patients and Their Potential for Increased Incidence of Cardiovascular Disorders”. Indian Journal of Public Health Research & Development 11, no. 8 (August 31, 2020): 206–213. Accessed May 12, 2025. https://medicopublication.com/index.php/ijphrd/article/view/10923.